Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Dev Regulatory News (FDEV)

Share Price Information for Frontier Dev (FDEV)

Share Price is delayed by 15 minutes
Get Live Data
407.00    7.50 (1.88%)
Bid:
404.50
Ask:
407.00
Spread: 2.50 (0.618%)
Market Cap: £141.39m
FDEV Live PriceLast checked at - London Stock Exchange

Intraday Frontier Dev Share Chart

FY21 Releases and Trading Update

28 Aug 2020 07:00

RNS Number : 3911X
Frontier Developments PLC
28 August 2020
 

Frontier Developments plc

FY21 Releases and Trading Update

Frontier Developments plc (AIM: FDEV, 'Frontier', the 'Group' or the 'Company'), a leading developer and publisher of videogames based in Cambridge, UK, provides an update on game and content releases for the 12 months to 31 May 2021 ('financial year 2021' or 'FY21').

At the Gamescom: Opening Night Live event on the evening of 27 August 2020, Frontier revealed three exciting new releases for FY21:

· Following the significant success of Jurassic World Evolution on PC, PS4 and Xbox One, Jurassic World Evolution: Complete Edition will bring the full experience to Nintendo Switch on November 3, 2020, and is available to pre-order now from the Nintendo eShop.

· Frontier Foundry, Frontier's new games label for third-party publishing, revealed its first two titles - the time-twisting turn-based combat strategy shooter Lemnis Gate, and physics-based co-op platformer Struggling. In both of these award-winning games, innovative gameplay sits at the heart of the development process.

· Struggling is out now on Steam and Nintendo Switch, making it the first Frontier Foundry title to launch and the start of Frontier Foundry's contribution to the Company, which is expected to become material to Frontier's overall business in the next few years.

· Lemnis Gate is available to wishlist on Steam now, and will be launching on PC, PlayStation 4 and Xbox One in early 2021, falling within FY21.

These three new game releases add to the already exciting roster for FY21:

· A major new era will be coming to Elite Dangerous in calendar Q1 2021, through Elite Dangerous: Odyssey, a highly anticipated paid update which will add a completely new dimension to the Elite Dangerous experience. Elite Dangerous: Odyssey will introduce on-foot gameplay across many aspects of the game, including exploration, combat and missions. This new era includes the addition of planets with light atmospheres and will bring familiar face-to-face personal scale to players and increase co-operative opportunities within the game.

· Planet Coaster, the leading rollercoaster park management game, is coming to the PlayStation 4, PlayStation 5, Xbox One and Xbox Series X later this year with Planet Coaster: Console Edition, with a rich new control system appropriate for a controller.

· Planet Zoo continues to thrive. The Planet Zoo: Australia Pack which released earlier this week, on 25 August, enables players to further expand their zoos with five iconic new animals, as well as a wealth of foliage, scenery and zoo construction pieces, all inspired by the diverse range of environments this majestic country has to offer. This new pack builds on the success of the Arctic Pack in December 2019 and the South America Pack in April 2020. Further packs are planned for FY21.

Frontier is very well placed for the future with these exciting releases for FY21 to support and extend our four existing and successful titles, together with new games published by Frontier Foundry. After a strong close to FY20, sales across all of our games in FY21 to date have been consistent with expectations. Taking into account actual performance to date and projections for the remainder of FY21, including the anticipated sales of future game/content/platform releases coming during the financial year, the Company is on track to deliver revenue within the top half of the current range of analyst projections of £83 million to £95 million for FY21 (the 12 months to 31 May 2021).

David Braben, Chief Executive, said:

"We've announced further releases to an already exciting line-up for FY21. Our team has done an amazing job developing strong releases for all four of our existing titles, and I am also looking forward to seeing the reaction to our first two Frontier Foundry games - Struggling and Lemnis Gate."

 

This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation (EU) 596/2014. The person responsible for making this announcement on behalf of the Company is Alex Bevis.

 

Enquiries:

 

Frontier Developments +44 (0)1223 394 300

David Braben, CEO

Alex Bevis, CFO

Liberum - Nomad and Joint Broker +44 (0)20 3100 2000

Neil Patel / Cameron Duncan

Jefferies - Joint Broker +44 (0)20 7029 8000

Max Jones / William Brown

Tulchan Communications +44 (0)20 7353 4200

Matt Low / Deborah Roney / David Allchurch

 

 

About Frontier Developments plc

Frontier is a leading independent developer and publisher of videogames founded in 1994 by David Braben, co-author of the iconic Elite game. Based in Cambridge, Frontier uses its proprietary COBRA game development technology to create innovative genre-leading games, primarily for personal computers and videogame consoles. As well as self-publishing internally developed games, Frontier also publishes games developed by carefully selected partner studios under its Frontier Foundry games label.

Frontier's LEI number: 213800B9LGPWUAZ9GX18.

www.frontier.co.uk

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTEAAPXALLEEAA
Date   Source Headline
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSDirector/PDMR Shareholding
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSDirector/PDMR Shareholding
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSDirector/PDMR Shareholding
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSDirector/PDMR Shareholding
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSDirector/PDMR Shareholding
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSDirector/PDMR Shareholding
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSDirector/PDMR Shareholding
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSDirector/PDMR Shareholding
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSDirector/PDMR Shareholding
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSDirector/PDMR Shareholding
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSDirector/PDMR Shareholding
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSDirector/PDMR Shareholding
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20267:00 amRNSDirector/PDMR Shareholding
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSLaunch of on-market Share Buyback Programme
26th Feb 20267:00 amRNSBlock Listing Return
11th Feb 202610:45 amRNSOption Grants / PDMR Dealings
27th Jan 20263:43 pmRNSHolding(s) in Company
14th Jan 20267:00 amRNSExcellent H1 Results & full year outlook upgraded
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer
2nd Jan 20267:00 amRNSAppointment of Chief Executive Officer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.